skip to main content
European Commission logo
en English

News article

Open Market Consultation: Next Generation Sequencing for Oncology

Increasing the use of Next Generation Sequencing (NGS) in oncology requires further cost and technology acceleration. 8 health procurers from 5 countries (BE, FR, DE, ES, IT) invite potentially interested bidders to participate in the online open market consultation meetings on 11-12 May 2021 in preparation of their upcoming oncNGS pre-commercial procurement. Aim of the procurement is to develop an affordable NGS tumor-marker analysis kit applicable to all tumor types that enables predictive, prognostic and diagnostic analysis in liquid biopsies.

Logo of the EU funded project on next generaion sequencingf for oncology
The logo shows a drop of blood with the name of the project oncNGS under it

permalinkMain URL

See alsoRegistration